Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.
<h4>Introduction</h4>Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its catalytic activity towards producing extra-testicular androgen. The present study is towards understanding interaction between biological, lifestyle and genetic impacts of AKR1C3 and their...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0217373 |
| _version_ | 1818841834046095360 |
|---|---|
| author | Nishi Karunasinghe Eva Symes Amy Gamage Alice Wang Pam Murray Shuotun Zhu Megan Goudie Jonathan Masters Lynnette R Ferguson |
| author_facet | Nishi Karunasinghe Eva Symes Amy Gamage Alice Wang Pam Murray Shuotun Zhu Megan Goudie Jonathan Masters Lynnette R Ferguson |
| author_sort | Nishi Karunasinghe |
| collection | DOAJ |
| description | <h4>Introduction</h4>Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its catalytic activity towards producing extra-testicular androgen. The present study is towards understanding interaction between biological, lifestyle and genetic impacts of AKR1C3 and their influence on clinical factors in a prostate cancer (PC) cohort from New Zealand (NZ).<h4>Method</h4>Characteristics of 516 PC patients were collected from the Auckland Regional Urology Facility, NZ. These men were genotyped for the AKR1C3 rs12529 single nucleotide polymorphism (SNP). The leukocyte AKR1C3 activity was measured in a sub-cohort. Variability of leukocyte AKR1C3 activity between biological, lifestyle and clinical features as well as correlation between biological and clinical features were assessed with and without genetic stratification.<h4>Results</h4>The leukocyte AKR1C3 activity was associated with age at diagnosis (0.51 vs 0.34 μM coumberol units for >69y vs ≤69y, P = 0.03); and with anatomic stage/prognostic grouping among the AKR1C3 rs12529 CC genotype carriers (0.50 vs 28 μM coumberol units among low- and high-risk groups respectively, P = 0.02). Significant correlation between leukocyte AKR1C3 activity and age at PC diagnosis was also observed (correlation coefficient 0.20 and P = 0.02). Ever- smoking impacted both age and PSA at PC diagnosis among AKR1C3 rs12529 GG and CG genotype carriers respectively. Age at diagnosis significantly correlated with PSA at diagnosis in the main (correlation coefficient 0.29, and P<0.001) and sub-cohorts (correlation coefficient 0.24, and P = 0.01); and those carrying the AKR1C3 rs12529 CG and GG genotypes in both the main (correlation coefficient 0.30, and P<0.001 and correlation coefficient 0.35, and P<0.001 respectively) and sub-cohorts (correlation coefficient 0.43, and P<0.001 and correlation coefficient 0.39, and P = 0.06 respectively); but not with those carrying the CC genotype.<h4>Conclusions</h4>Age dependent PSA thresholds in PC screening could have been valid only in men carrying the AKR1C3 rs12529 CG and GG genotypes in this NZ cohort. |
| first_indexed | 2024-12-19T04:32:22Z |
| format | Article |
| id | doaj.art-2863d6f5e91a4d71bdc10c8d79b1d3fc |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-19T04:32:22Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2863d6f5e91a4d71bdc10c8d79b1d3fc2022-12-21T20:35:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01145e021737310.1371/journal.pone.0217373Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.Nishi KarunasingheEva SymesAmy GamageAlice WangPam MurrayShuotun ZhuMegan GoudieJonathan MastersLynnette R Ferguson<h4>Introduction</h4>Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its catalytic activity towards producing extra-testicular androgen. The present study is towards understanding interaction between biological, lifestyle and genetic impacts of AKR1C3 and their influence on clinical factors in a prostate cancer (PC) cohort from New Zealand (NZ).<h4>Method</h4>Characteristics of 516 PC patients were collected from the Auckland Regional Urology Facility, NZ. These men were genotyped for the AKR1C3 rs12529 single nucleotide polymorphism (SNP). The leukocyte AKR1C3 activity was measured in a sub-cohort. Variability of leukocyte AKR1C3 activity between biological, lifestyle and clinical features as well as correlation between biological and clinical features were assessed with and without genetic stratification.<h4>Results</h4>The leukocyte AKR1C3 activity was associated with age at diagnosis (0.51 vs 0.34 μM coumberol units for >69y vs ≤69y, P = 0.03); and with anatomic stage/prognostic grouping among the AKR1C3 rs12529 CC genotype carriers (0.50 vs 28 μM coumberol units among low- and high-risk groups respectively, P = 0.02). Significant correlation between leukocyte AKR1C3 activity and age at PC diagnosis was also observed (correlation coefficient 0.20 and P = 0.02). Ever- smoking impacted both age and PSA at PC diagnosis among AKR1C3 rs12529 GG and CG genotype carriers respectively. Age at diagnosis significantly correlated with PSA at diagnosis in the main (correlation coefficient 0.29, and P<0.001) and sub-cohorts (correlation coefficient 0.24, and P = 0.01); and those carrying the AKR1C3 rs12529 CG and GG genotypes in both the main (correlation coefficient 0.30, and P<0.001 and correlation coefficient 0.35, and P<0.001 respectively) and sub-cohorts (correlation coefficient 0.43, and P<0.001 and correlation coefficient 0.39, and P = 0.06 respectively); but not with those carrying the CC genotype.<h4>Conclusions</h4>Age dependent PSA thresholds in PC screening could have been valid only in men carrying the AKR1C3 rs12529 CG and GG genotypes in this NZ cohort.https://doi.org/10.1371/journal.pone.0217373 |
| spellingShingle | Nishi Karunasinghe Eva Symes Amy Gamage Alice Wang Pam Murray Shuotun Zhu Megan Goudie Jonathan Masters Lynnette R Ferguson Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. PLoS ONE |
| title | Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. |
| title_full | Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. |
| title_fullStr | Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. |
| title_full_unstemmed | Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. |
| title_short | Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. |
| title_sort | interaction between leukocyte aldo keto reductase 1c3 activity genotypes biological lifestyle and clinical features in a prostate cancer cohort from new zealand |
| url | https://doi.org/10.1371/journal.pone.0217373 |
| work_keys_str_mv | AT nishikarunasinghe interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT evasymes interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT amygamage interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT alicewang interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT pammurray interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT shuotunzhu interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT megangoudie interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT jonathanmasters interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand AT lynnetterferguson interactionbetweenleukocytealdoketoreductase1c3activitygenotypesbiologicallifestyleandclinicalfeaturesinaprostatecancercohortfromnewzealand |